Evolution of fluoroquinolone-resistant Escherichia coli in the gut after ciprofloxacin treatment - de Lastours, V.; El Meouche, I.; Chau, F.; Beghain, J.; Chevret, D.; Aubert-Frambourg, A.; Clermont, O.; Royer, G.; Bouvet, O.; Denamur, E.; Fantin, B. (International journal of medical microbiology, 2022)
Keywords: Anti-Bacterial Agents - pharmacology; Ciprofloxacin; Ciprofloxacin - pharmacology; Drug Resistance, Bacterial - genetics; Escherichia coli; Escherichia coli - drug effects; Escherichia coli - genetics; Escherichia coli Infections - drug therapy; Escherichia coli Infections - microbiology; Fluoroquinolones - pharmacology; Gastrointestinal Tract - microbiology; Gut microbiota; Humans; Life Sciences; Microbial Sensitivity Tests; Proteomics; Tolerance; Whole genome sequencing; Gut microbiota; Tolerance; Ciprofloxacin; Whole genome sequencing; Escherichia coli; Proteomics; Escherichia coli Ciprofloxacin Tolerance Proteomics Whole genome sequencin